No early win for Sanofi, Regeneron cholesterol drug in study
November 17, 2016 at 04:50 AM EST
Nov 17 (Reuters) - Sanofi and Regeneron Pharmaceuticals said on Thursday they would continue a large clinical outcomes study with their injectable cholesterol-lowering drug Praluent.
